Founder Fubon CSI Medicine and Medical Device Innovation ETF(560600.SH)

Company Encyclopedia

Founder Fubon CSI Medicine and Medical Device Innovation ETF

560600.SH

Shareholder

Ownership	%Owned	Share Chg	Report Date
No Data

News

Sunho Biologics CEO and Chief Scientific Officer Dr. Yin Liusong to Step Down

Sunho Biologics, Inc. announced that Dr. Yin Liusong will resign as CEO and Chief Scientific Officer effective February 28, 2026, to pursue other opportunities. He stated there is no disagreement with the board, and he will ensure a smooth transition while the company searches for replacements. This leadership change may impact the company's strategic direction. The current analyst rating for Sunho Biologics (HK:2898) is a Hold with a price target of HK$7.00.

Tip Ranks·8 Hours ago

China Resources Pharmaceutical Calls 2026 EGM to Approve Sales Framework and New Articles

China Resources Pharmaceutical Group Ltd. has scheduled its first extraordinary general meeting for February 6, 2026, in Beijing. Shareholders will vote on a new Sales Framework Agreement for 2026-2028 and a special resolution to adopt new Articles of Association, potentially updating the company's governance framework. The current analyst rating for the stock (HK:3320) is a Hold with a price target of HK$5.00. The company operates in the pharmaceutical sector in mainland China, with a market cap of HK$28.52B and a year-to-date price performance of 2.02%.

Tip Ranks·11 Hours ago